++
For further information, see CMDT Part 22-15: IgG4-Related Disease
+++
Essentials of Diagnosis
++
Protean manifestations caused by lymphoplasmacytic infiltrates in any organ or tissue, especially the pancreas, lacrimal glands, biliary tract, and retroperitoneum
Subacute onset; constitutional symptoms rare
Diagnosis rests on specific histopathological findings that include presence of IgG4-bearing plasma cells
+++
General Considerations
++
A systemic disorder of unknown cause
Any organ of the body can be affected
Marked by highly characteristic fibroinflammatory changes
Severity ranges from asymptomatic to organ- or life-threatening
++
++
Can affect any organ of the body
Lymphoplasmacytic infiltrates, fibrosis, and phlebitis may be localized or generalized
Disease ranges in severity from asymptomatic to organ- or life-threatening
Inflammatory infiltration frequently produces tumefactive masses that can be found on physical examination
Enlargement of submandibular glands
Proptosis from periorbital infiltration
Retroperitoneal fibrosis, mediastinal fibrosis
Inflammatory aortic aneurysm
Pancreatic mass with autoimmune pancreatitis
Can also affect the thyroid (formerly Riedel thyroiditis), kidney, meninges, pituitary, sinuses, lung, prostate, breast, and bone
Fever and constitutional symptoms are usually absent
Nearly half of patients also have allergic disorders such as sinusitis or asthma
+++
Differential Diagnosis
++
Sarcoidosis
Sjögren syndrome
Pancreatic cancer (pancreatic mass)
Chronic infections (HIV, hepatitis C)
Granulomatosis with polyangiitis (proptosis)
Lymphoma
++
++
+++
Diagnostic Procedures
++
++
Asymptomatic patients without organ-threatening disease can be monitored carefully
Initial therapy is usually oral prednisone, 0.6 mg/kg/d, tapered over weeks or months depending on response
Given that corticosteroid monotherapy may fail to control the disease and can cause significant long-term toxicity, immunosuppressants, especially rituximab, are often used
++
++
++